TLP Group’s Regenxbio RGNX Stock Holding History

TLP Group’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,575	Closed	-$106K	–	355
2016 Q3	$106K	Buy	+7,575	New	+$83.6K	0.11%	212

Other funds holding RGNX

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

TLP Group's RGNX Position: Q4 2016 in Review

TLP Group sold out of Regenxbio (RGNX) in Q4 2016, closing a stake of 7,575 shares — an estimated $106K sold.

TLP Group first reported a position in RGNX in Q3 2016 and held it in 1 quarter. The position peaked at $106K in Q3 2016. 78 funds tracked by Wall St. Rank hold RGNX as of Q4 2016.

TLP Group reported no remaining Regenxbio position as of Q4 2016 after selling out during the quarter.
TLP Group sold 7,575 Regenxbio shares in Q4 2016, an estimated $106K.
TLP Group first reported a position in Regenxbio in Q3 2016 and held it in 1 quarter.
TLP Group's Regenxbio position peaked at $106K in Q3 2016.
78 funds tracked by Wall St. Rank held Regenxbio as of Q4 2016.

Based on TLP Group's 13F filing for Q4 2016, filed 2 Feb 2017.